Skip to main content
Fig. 5 | BMC Medical Genomics

Fig. 5

From: Identification and validation of a novel predictive signature based on hepatocyte-specific genes in hepatocellular carcinoma by integrated analysis of single-cell and bulk RNA sequencing

Fig. 5

Construction and evaluation of the predictive signature. (A) Analysis of the overall survival of patients with HCC from TCGA, ICGC, and summary cohorts. (B-C) The distribution of patient’s survival and gene expression in the high-and low-risk groups was analyzed by utilizing the training cohort (TCGA-LIHC) and the validation cohort (ICGC-LIRI-JP). (D) The ROC curve for the training cohort (TCGA-LIHC). (E) The ROC curve for the validation cohort (ICGC-LIRI-JP). Differences were considered statistically significant at P < 0.05

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us